Strength
1 mg/1
Manufacturer
Biocon Pharma Inc.NDC
70377011211
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
EVEROLIMUSApproval Type
Generic (ANDA)
FDA Application
ANDA216140On Market Since
6/2/2025
Pharmacological Classes
Cytochrome P450 2D6 Inhibitors
Cytochrome P450 3A4 Inhibitors
Decreased Immunologic Activity
Kinase Inhibitor
Protein Kinase Inhibitors
mTOR Inhibitor Immunosuppressant
mTOR Inhibitors
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.
Related Drugs
Same classification
SERTRALINE HCL 25 MG TABLET
Generic
00904692461•Major Pharmaceuticals
$0.0300
per EA
SERTRALINE HCL 25 MG TABLET
Generic
16714061101•NorthStar Rx LLC
$0.0300
per EA
SERTRALINE HCL 25 MG TABLET
Generic
16714061104•NorthStar Rx LLC
$0.0300
per EA
SERTRALINE HCL 25 MG TABLET
Generic
16714061105•NorthStar Rx LLC
$0.0300
per EA
SERTRALINE HCL 25 MG TABLET
Generic
16714061106•NorthStar Rx LLC
$0.0300
per EA
SERTRALINE HCL 25 MG TABLET
Generic
16729021515•Accord Healthcare Inc.
$0.0300
per EA
SERTRALINE HCL 25 MG TABLET
Generic
16729021516•Accord Healthcare Inc.
$0.0300
per EA
SERTRALINE HCL 25 MG TABLET
Generic
23155075705•Heritage Pharmaceuticals Inc.
$0.0300
per EA
SERTRALINE HCL 25 MG TABLET
Generic
23155075709•Heritage Pharmaceuticals Inc.
$0.0300
per EA
SERTRALINE HCL 25 MG TABLET
Generic
31722014505•Camber Pharmaceuticals Inc.
$0.0300
per EA